Cognition Therapeutics, Inc. Stock Forecast
Weaker technical forecast for Cognition Therapeutics, Inc. as stock downgraded to Sell Candidate.
(Updated on May 03, 2024)
The Cognition Therapeutics, Inc. stock price fell by -2.53% on the last day (Friday, 3rd May 2024) from $1.98 to $1.93. During the last trading day the stock fluctuated 5.26% from a day low at $1.90 to a day high of $2.00. The price has been going up and down for this period, and there has been a 4.89% gain for the last 2 weeks. Volume has increased on the last day by 8 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 63 thousand shares were bought and sold for approximately $122.23 thousand.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.88% during the next 3 months and, with a 90% probability hold a price between $1.49 and $1.83 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CGTX Signals & Forecast
The Cognition Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.94. On a fall, the stock will find some support from the long-term average at approximately $1.92. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -7.66%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Cognition Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Cognition Therapeutics, Inc. stock
Cognition Therapeutics, Inc. finds support from accumulated volume at $1.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.100 between high and low, or 5.26%. For the last week, the stock has had daily average volatility of 5.67%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CGTX) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Cognition Therapeutics, Inc. to open at $1.94, and during the day (based on 14 day Average True Range), to move between $1.80 and $2.06, which gives a possible trading interval of +/-$0.129 (+/-6.68%) up or down from last closing price. If Cognition Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.36% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.96 (1.55%) than the support at $1.89 (2.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Cognition Therapeutics, Inc. stock A Buy?
Cognition Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -2.807 Sell Candidate Downgraded
Predicted Opening Price for Cognition Therapeutics, Inc. of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $1.94 ( 0.691%) | $1.93 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CGTX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.04 | 5.87 % | |
| R2 | 2.01 | 3.89 % | ||
| R1 | 1.98 | 2.67 % | ||
| Current price: | 1.93 | |||
| Support | S1 | 1.91 | -1.29 % | |
| S2 | 1.88 | -2.51 % | ||
| S3 | 1.84 | -4.49 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.98 | 2.59 % | |
| R2 | 1.97 | 2.07 % | ||
| R1 | 1.96 | 1.55 % | ||
| Current price | 1.93 | |||
| Support | S1 | 1.89 | -2.07% | |
| S2 | 1.84 | -4.66% | ||
| S3 | 1.82 | -5.70% |
FAQ
Click here for our free guide on how to buy Cognition Therapeutics, Inc. Stock.
